Bruton's tyrosine kinase inhibitors in multiple sclerosis: pioneering the path towards treatment of progression? Geladaris, A., Torke, S. ORCID: https://orcid.org/0000-0002-1029-3623 and Weber, M.S. CNS drugs 36 (10): 1019-1030. October 2022
![[feed]](/style/images/feed-icon-14x14.png){kind=icon}
![[up]](/style/images/multi_up.png)
Up a level
